NCT00814021 2026-04-15
Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain
Institut Claudius Regaud
Phase 2 Completed
Clinical Trials
424 trialsNCT04028245 2026-04-15
SPARC-1
Columbia University
Phase EARLY_PHASE1 Completed
NCT05410509 2026-04-14
"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"
University of Alabama at Birmingham
Phase NA Completed
NCT04416646 2026-04-13
ZEBRA
Istituto Oncologico Veneto IRCCS
Completed
NCT06020651 2026-04-08
VICKI
Institut Mutualiste Montsouris
Phase NA Completed
NCT03841149 2026-04-03
VolUS3D
Assistance Publique - Hôpitaux de Paris
Completed
NCT02555748 2026-03-31
SUP-R
Institut Claudius Regaud
Phase 4 Completed
NCT04960059 2026-03-19
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The Christie NHS Foundation Trust
Completed
NCT07004426 2026-03-19
KIDCaD
Charles University, Czech Republic
Completed
NCT07436416 2026-02-27
EXO-RENAL2
Institute of Oncology Ljubljana
Phase NA Completed
NCT07406646 2026-02-12
EXO-RENAL1
Institute of Oncology Ljubljana
Phase NA Completed
NCT01625351 2026-02-06
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
St. Jude Children's Research Hospital
Phase 1 Completed
NCT00625755 2026-01-23
A Phase I/II Study to Assess the Safety and Efficacy of Vaccinations With Allogeneic Dendritic Cells: Autologous Tumor-Derived Cells Subjected to Electrofusions in Patients With AJCC Stage IV Renal Cell Carcinoma
Beth Israel Deaconess Medical Center
Phase 1/2 Completed
NCT06138496 2026-01-05
Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
Sun Yat-sen University
Phase 2 Completed
NCT04601129 2025-12-23
RREIN
University Hospital, Lille
Completed
NCT04501913 2025-12-05
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
City of Hope Medical Center
Completed
NCT05579847 2025-12-04
Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy
H. Lee Moffitt Cancer Center and Research Institute
Completed
NCT05377632 2025-11-28
PIONEER-OPT
Kantonsspital Baden
Phase NA Completed
NCT07232927 2025-11-18
HEMOSTA-PN
Ankara University
Phase NA Completed
NCT02162732 2025-11-03
Molecular-Guided Therapy for Childhood Cancer
Milton S. Hershey Medical Center
Phase NA Completed
NCT03075423 2025-09-26
Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC
Goethe University
Phase 2 Completed
NCT07181954 2025-09-19
CT-based Radiomics for Prediction of MIT Family Translocation Kidney Cancer: a Multicenter, Retrospective Clinical Study
First Affiliated Hospital of Fujian Medical University
Completed
NCT04758507 2025-09-08
TACITO
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 1/2 Completed
NCT00930033 2025-09-05
CARMENA
Assistance Publique - Hôpitaux de Paris
Phase 3 Completed
NCT05263245 2025-09-03
Skippy 1
Leiden University Medical Center
Phase 2 Completed
NCT03948724 2025-08-17
EDHITO
Institut Cancerologie de l'Ouest
Phase NA Completed
NCT07117786 2025-08-12
Computed Tomography Radiomics-Derived Nomogram for Predicting Early Renal Function Decline After Partial Nephrectomy in Renal Cell Carcinoma: A Multicenter Development/Validation Study
First Affiliated Hospital of Fujian Medical University
Completed
NCT03685448 2025-08-08
UNICAB
Australian and New Zealand Urogenital and Prostate Cancer Trials Group
Phase 2 Completed
NCT03967522 2025-08-08
CABRAMET
Centre Leon Berard
Phase 2 Completed
NCT04508725 2025-07-25
Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC)
Stanford University
Phase NA Completed
NCT04627064 2025-07-25
ABEMA Alone or in COMBO With MK-6482
Dana-Farber Cancer Institute
Phase 1 Completed
NCT05404685 2025-06-13
P-NeLoP
University Hospital, Bordeaux
Phase NA Completed
NCT03297593 2025-06-06
Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma
Swiss Cancer Institute
Phase 2 Completed
NCT04337970 2025-05-28
Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer
Memorial Sloan Kettering Cancer Center
Phase 1/2 Completed
NCT02899078 2025-05-18
Ibrutinib and Nivolumab in Treating Patients With Previously-Treated Metastatic Kidney Cancer
University of California, Davis
Phase 1/2 Completed
NCT02318771 2025-05-15
Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer
Thomas Jefferson University
Phase 1 Completed
NCT06969131 2025-05-13
Current Role of Pentafecta Outcomes in Open and Laparoscopic Partial Nephrectomy for Localized Renal Tumors
South Valley University
Phase NA Completed
NCT06960135 2025-05-07
Trifecta
South Valley University
Phase NA Completed
NCT02440334 2025-05-04
Two and Three Dimensional Contrast-enhanced Ultrasound for Screening of Renal Cell Carcinoma Recurrence Following Cryoablation
Thomas Jefferson University
Phase 2 Completed
NCT04802824 2025-05-02
Measuring Treatment Response in Metastatic Renal Cell Cancer Using FPIA PET/CT
Imperial College London
Completed
NCT03324373 2025-04-24
Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC)
University of Iowa
Phase 1 Completed
NCT05976607 2025-04-17
Clinical Study of 18F -FAPI-RGD in Renal Tumor
Sichuan Provincial People's Hospital
Completed
NCT06883565 2025-03-19
Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study
Fudan University
Completed
NCT06876584 2025-03-14
The CT-based Deep Learning Model Predicts Complications in Partial Nephrectomy
Fudan University
Completed
NCT03149822 2025-03-13
Study of Pembrolizumab and Cabozantinib in Patients With Metastatic Renal Cell Carcinoma
University of Colorado, Denver
Phase 1/2 Completed
NCT04537247 2025-03-12
A Comparative Study Between Open and Robotic Partial Nephrectomy in Treatment of High Complex Renal Tumors.
Assiut University
Phase NA Completed
NCT03891485 2025-03-11
REVOLUTION
National Cancer Institute, Naples
Completed
NCT01767636 2025-03-03
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer
Mayo Clinic
Phase 2 Completed
NCT03190174 2025-02-17
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
Sarcoma Oncology Research Center, LLC
Phase 1/2 Completed
NCT06829888 2025-02-17
CRYO-BO-2021
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Completed